Elite in Ulcerative Colitis

Anne M. Griffiths

555 University Ave, M5G 1X8, 
Toronto, ON, CA 
Elite in Ulcerative Colitis
555 University Ave, M5G 1X8, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Anne Griffiths practices in Toronto, Canada. Ms. Griffiths is rated as an Elite expert by MediFind in the treatment of Ulcerative Colitis. Her top areas of expertise are Crohn's Disease, Viral Gastroenteritis, Colitis, Endoscopy, and Colonoscopy.

Her clinical research consists of co-authoring 271 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 101 articles and participated in 3 clinical trials in the study of Ulcerative Colitis.

Gender
Female

Locations

555 University Ave, M5G 1X8, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
Enrollment Status: Active_not_recruiting
Publish Date: April 17, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
A Multicenter, Open-Label PK Study of Mirikizumab in Pediatric Patients With Moderately to Severely Active Ulcerative Colitis
A Multicenter, Open-Label PK Study of Mirikizumab in Pediatric Patients With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Completed
Publish Date: March 26, 2024
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
Manipulating the Microbiome in IBD by Antibiotics and Fecal Microbiota Transplantation (FMT): a Randomized Controlled Trial
Manipulating the Microbiome in IBD by Antibiotics and Fecal Microbiota Transplantation (FMT): a Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: October 08, 2021
Intervention Type: Drug
Study Drugs: Vancomycin, Amoxycillin, Doxycyline, Ciprofloxacin, Methylprednisolone, Metronidazole
Study Phase: Not Applicable
A Pragmatic Randomized Controlled Trial on High Dose Vitamin D to Prevent Relapses of Crohn's Disease in Children
A Pragmatic Randomized Controlled Trial on High Dose Vitamin D to Prevent Relapses of Crohn's Disease in Children
Enrollment Status: Unknown
Publish Date: September 23, 2020
Intervention Type: Drug
Study Drug: Cholecalciferol
Study Phase: Phase 3
Randomized Controlled Trial of High Dose Vitamin D in Children With Newly Diagnosed Crohn's Disease for the Prevention of Relapses
Randomized Controlled Trial of High Dose Vitamin D in Children With Newly Diagnosed Crohn's Disease for the Prevention of Relapses
Enrollment Status: Completed
Publish Date: September 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study
IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study
Enrollment Status: Completed
Publish Date: May 31, 2019
Intervention Type: Biological
View 6 Less Clinical Trials

270 Total Publications

Metabolomics reveal distinct molecular pathways associated with future risk of Crohn's Disease.
Metabolomics reveal distinct molecular pathways associated with future risk of Crohn's Disease.
Journal: Gut microbes
Published: September 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Griffiths's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile